©2024 Stanford Medicine
Study to Examine the Effects of MultiStem in Ischemic Stroke
Not Recruiting
Trial ID: NCT01436487
Purpose
A study to examine the safety and potential effectiveness of the adult stem cell
investigational product, MultiStem, in adults who have suffered an ischemic stroke. The
hypothesis is that MultiStem will be safe and provide benefit following an ischemic stroke.
Official Title
Double-Blind, Randomized, Placebo-Controlled Phase 2 Safety and Efficacy Trial of MultiStem® in Adults With Ischemic Stroke
Stanford Investigator(s)
Nirali Vora
Clinical Professor, Neurology & Neurological Sciences
Eligibility
Inclusion Criteria:
- Male or female subjects between 18 and 83 years of age (inclusive)
- Clinical diagnosis of cortical cerebral ischemic stroke
- Occurrence of a moderate to moderately severe stroke
Exclusion Criteria:
- Presence of a lacunar or a brainstem infarct
- Reduced level of consciousness
- Major neurological event such as stroke or clinically significant head trauma within 6
months of study
Intervention(s):
biological: MultiStem
biological: Placebo
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Neil Schwartz
6507237193